查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1544658

绵羊及山羊人工授精市场、机会、成长动力、产业趋势分析与预测，2024-2032

Ovine and Caprine Artificial Insemination Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 185 Pages | 商品交期: 2-3个工作天内

价格
简介目录

在生殖技术进步和对改善牲畜遗传学的关注的推动下，全球绵羊和山羊人工授精市场在 2024 年至 2032 年间将实现 5.8% 的复合年增长率。创新人工智慧技术的整合提高了绵羊和山羊族群的生育率和遗传多样性，满足了对优质肉类和牛奶不断增长的需求。在此背景下，2024年1月，农业、食品安全和企业部（MAFSE）宣布，台湾与伯利兹于2015年12月启动的绵羊和山羊基因改良计画取得了重大进展。该措施旨在透过综合方法改善品种品质、基础设施和农民教育，从而提升伯利兹的小型反刍动物部门。

此外，商业畜牧业的扩张以及农民对人工智慧好处的认识不断提高，也有助于市场成长，因为这些做法可以实现更好的畜群管理和生产力。

绵羊和山羊人工授精市场根据类型、动物类型、技术、最终用途和地区进行细分。

由于越来越多地采用需要精确可靠工具的复杂生殖技术，设备领域将在 2032 年显着成长。随着农民和育种者寻求优化生育力并确保成功的授精程序，对提高准确性、效率和易用性的先进设备的需求变得至关重要。人们对育种过程中技术精度的日益关注推动了对高品质设备的需求，这些设备旨在支援成功的人工智慧实践并提高牲畜生产力。

由于山羊在不同农业领域中的作用不断扩大，到 2032 年，山羊/山羊细分市场将占据显着的收入份额。随着对肉、乳和纤维等山羊产品的需求增加，对提高畜群品质和生产力的有效育种方法的需求也随之增加。对增强山羊遗传性状的重视促进了人工授精技术的采用，促进了山羊族群的更好管理和优化。

在政府对先进农业实践的支持和资助不断增加的推动下，2024年至2032年欧洲绵羊和山羊人工授精产业将呈现显着成长。随着欧洲国家注重提高畜牧业生产力和永续性，旨在推广现代育种技术的政策和补贴发挥至关重要的作用。消费者对优质绵羊和山羊产品的需求不断增长，也鼓励农民采用人工授精来改善畜群遗传并满足需求。对改善动物福利和减少育种相关挑战的重视支持了整个地区绵羊和山羊人工授精市场的扩大。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 肉类和乳製品消费量上升
      • 人工授精技术的创新
      • 政府和农业组织的支持
    • 产业陷阱与挑战
      • 手续费用高
      • 在某些地区获得技术的机会有限
  • 成长潜力分析
  • 技术景观
  • 未来市场趋势
  • 波特的分析
  • PESTEL分析

第 4 章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章：市场估计与预测：按类型，2021 - 2032

  • 主要趋势
  • 装置
  • 精液
    • 正常精液
    • 性精液
  • 试剂及试剂盒
  • 服务

第 6 章：市场估计与预测：按动物类型，2021 - 2032

  • 主要趋势
  • 绵羊/绵羊
  • 山羊/山羊

第 7 章：市场估计与预测：按技术分类，2021 - 2032 年

  • 主要趋势
  • 阴道
  • 子宫颈
  • 宫内

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

  • 主要趋势
  • 兽医院
  • 兽医诊所
  • 其他最终用户

第 9 章：市场估计与预测：按地区划分，2021 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 波兰
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 10 章：公司简介

  • Agtech, Inc.
  • B and D Genetics
  • Continental Genetics, LLC
  • IMV Technologies Group
  • Jorgensen Laboratories
  • MINITUB GMBH
  • Neogen Corporation
  • Nasco
  • Reproduction Provisions LLC
  • SEK Genetics
  • Zoetis Inc.
简介目录
Product Code: 10193

Global Ovine and Caprine Artificial Insemination Market will experience a 5.8% CAGR between 2024 and 2032, driven by advancements in reproductive technologies and a focus on improving livestock genetics. The integration of innovative AI techniques enhances fertility rates and genetic diversity in sheep and goat populations, meeting the rising demand for high-quality meat and milk. Against this backdrop, in January 2024, the Ministry of Agriculture, Food Security, and Enterprise (MAFSE) announced that the Genetic Improvement in Sheep and Goat Project, a Taiwan-Belize collaboration launched in December 2015, has made significant strides. This initiative aims to elevate Belize's small ruminant sector by improving breed quality, infrastructure, and farmer education through a comprehensive approach.

Additionally, the expansion of commercial livestock farming and the increasing awareness among farmers about the benefits of AI contribute to market growth, as these practices enable better herd management and productivity.

The ovine and caprine artificial insemination market is segmented based on type, animal type, technique, end-use, and region.

The equipment segment will record a significant growth rate through 2032, owing to the growing adoption of sophisticated reproductive technologies that require precise and reliable tools. As farmers and breeders seek to optimize fertility and ensure successful insemination procedures, the need for advanced equipment that offers improved accuracy, efficiency, and ease of use becomes crucial. This increased focus on technological precision in the breeding process drives the demand for high-quality equipment designed to support successful AI practices and improve livestock productivity.

The caprine/goat segment will acquire a noteworthy revenue share by 2032, due to the expanding role of goats in diverse agricultural sectors. As demand for goat products such as meat, milk, and fiber increases, so does the need for effective breeding methods to improve herd quality and productivity. The emphasis on enhancing genetic traits in goats ushers in the adoption of artificial insemination techniques, facilitating better management and optimization of goat populations.

Europe ovine and caprine artificial insemination industry will show a significant growth rate from 2024 to 2032, driven by increasing government support and funding for advanced agricultural practices. As European countries focus on enhancing livestock productivity and sustainability, policies, and subsidies aimed at promoting modern breeding technologies play a crucial role. The rising consumer demand for high-quality sheep and goat products also encourages farmers to adopt artificial insemination to improve herd genetics and meet needs. The emphasis on improving animal welfare and reducing breeding-related challenges supports the expansion of the ovine and caprine artificial insemination market across the region.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising meat and dairy consumption
      • 3.2.1.2 Innovations in artificial insemination techniques
      • 3.2.1.3 Support from governments and agricultural organizations
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of procedures
      • 3.2.2.2 Limited access to technology in certain regions
  • 3.3 Growth potential analysis
  • 3.4 Technology landscape
  • 3.5 Future market trends
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Equipment
  • 5.3 Semen
    • 5.3.1 Normal semen
    • 5.3.2 Sexed semen
  • 5.4 Reagent and kits
  • 5.5 Services

Chapter 6 Market Estimates and Forecast, By Animal Type, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Ovine/sheep
  • 6.3 Caprine/goat

Chapter 7 Market Estimates and Forecast, By Technique, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Vaginal
  • 7.3 Cervical
  • 7.4 Intrauterine

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Veterinary hospitals
  • 8.3 Veterinary clinics
  • 8.4 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Poland
    • 9.3.7 Netherlands
    • 9.3.8 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Agtech, Inc.
  • 10.2 B and D Genetics
  • 10.3 Continental Genetics, LLC
  • 10.4 IMV Technologies Group
  • 10.5 Jorgensen Laboratories
  • 10.6 MINITUB GMBH
  • 10.7 Neogen Corporation
  • 10.8 Nasco
  • 10.9 Reproduction Provisions LLC
  • 10.10 SEK Genetics
  • 10.11 Zoetis Inc.